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Introduction {#sec001}
============

The climacteric is a natural phase of the woman's life that comprises the transition between the reproductive and the non-reproductive period \[[@pone.0237336.ref001]\]. Biologically, it is understood as a set of changes in the ovarian structure and function, with a decrease in the production of steroid hormones \[[@pone.0237336.ref002]\]. This important life stage starts when the woman is approximately 40 years old and lasts until the age of 60--65 years. It is characterized by hormonal changes and functional, morphological, psychogenic and physical modifications \[[@pone.0237336.ref003]\]. It is believed that, of life's several phases, the climacteric is the one that causes the greatest impact on the woman's health \[[@pone.0237336.ref004]\].

Among different changes that affect the health of the climacteric woman, obesity occupies a prominent position. This pathology has a complex and multifactorial etiology with an epidemic character \[[@pone.0237336.ref005]\] and is considered a severe public health problem worldwide \[[@pone.0237336.ref003]\]. In Brazil, data from the Surveillance System of Risk and Protection Factors for Chronic Diseases by Telephone Survey (VIGITEL) of the year of 2017 showed that overweight was present in 50.5% of the women, increasing as age increases up to 64 years \[[@pone.0237336.ref006]\]. Moreover, a study conducted with the climacteric population found that more than 35.0% of these women were diagnosed with obesity \[[@pone.0237336.ref007]\].

During the climacteric stage, fat accumulation is redistributed from peripheral locations to intra-abdominal deposits, resulting in abdominal obesity. This has been one of the most worrying climacteric symptoms among women \[[@pone.0237336.ref008]\], and can be related to genetic, exogenous and mainly hormonal factors. In women, estrogen is the hormone responsible for fat accumulation in the subcutaneous tissue, particularly in the gluteal and femoral regions, while the androgens are responsible for abdominal fat accumulation \[[@pone.0237336.ref009]\]. However, in this phase, estrogen levels decrease, causing hyperandrogenemia and resulting in fat redistribution from the gynoid to the android (abdominal) position \[[@pone.0237336.ref009]--[@pone.0237336.ref011]\].

Abdominal obesity has been one of the main public health problems and has drawn researchers' attention, not only because it affects a considerable number of women, but also due to its strong correlation with an increase in morbidity and mortality risks \[[@pone.0237336.ref012]\]. Thus, researching into abdominal obesity has become relevant, as the conditions of women, mainly those in the climacteric phase, represent a challenge to Primary Care due to its low capacity for meeting these women's real needs. In this context, the present study aimed to investigate the prevalence and factors associated with abdominal obesity in climacteric women assisted at Family Health Strategy units of the city of Montes Claros---State of Minas Gerais.

Methods {#sec002}
=======

This is a cross-sectional, analytical study that is part of a larger project called "Health problems in climacteric women: An epidemiological study". It was developed at the Family Health Strategy units of the city of Montes Claros, State of Minas Gerais, Brazil. The Family Health Strategy is a project of Brazil's Ministry of Health to organize Primary Care and the Family Health units, with the aim of providing quality of life for the Brazilian population and intervening in factors that put health at risk \[[@pone.0237336.ref013]\].

The aforementioned project has a robust database, collected in 2015, with the participation of several researchers in the area, with two published articles \[[@pone.0237336.ref014], [@pone.0237336.ref015]\], both cross-sectional studies. The first evaluated the quality of life and associated factors of climacteric women \[[@pone.0237336.ref014]\]. The second investigated the association between health conditions and overweight in climacteric women, and in addition to the outcome variable, overweight and obesity, other variables such as sociodemographic, reproductive, clinical, eating and behavioural factors were evaluated \[[@pone.0237336.ref015]\]. In this study, the purpose was to verify the variables associated with waist circumference because we believe it is relevant to adopt it as a routine measure in Primary Care for climacteric women, with evidences between this and physical inactivity, the increase in the total levels of cholesterol and hypertension.

The final sample of the present study differs from others in the same population group previously published \[[@pone.0237336.ref014], [@pone.0237336.ref015]\], since women who were not attended to measure waist circumference, a dependent variable in this study, were excluded from the sample. Those who did not answer the questionnaire about food were also excluded, as it is believed to be essential to carry out the association with the dependent variable.

The target population was composed of 30,018 climacteric women enrolled in 73 healthcare units. Pregnant, postpartum or bedridden women were excluded, and women who did not attend the data collection session after three attempts were considered losses. For sample size determination, the formula to estimate prevalence in cross-sectional studies was used \[[@pone.0237336.ref016]\]. To perform the calculation, a confidence level of 95% was adopted, with precision of 5% and a 50% prevalence of abdominal obesity. An adjustment for design effect was performed and a deff of 2.0 was adopted.

The sample was selected by probabilistic two-stage cluster sampling. In the first stage, the method of probability proportional to size (PPS) was used, and 20 Family Health Strategy units were selected in urban and rural areas. In the second stage, 48 women were drawn by simple random sampling (SRS) in each selected unit. To incorporate the structure of the complex sampling design into the statistical analysis, each woman was associated to a weight (w), which corresponded to the inverse of that woman's probability of being included in the sample (*f*) \[[@pone.0237336.ref017]\]. Women aged between 40 and 65 years who were physically able to answer the questionnaires were considered eligible to participate in the study. The calculations determined a sample size of at least 760 women.

A pilot study was carried out at one Family Health Strategy unit, with women belonging to the studied age group who were not selected for the final sample. This enabled to test the questionnaire and the interviewers' performance in practice. After this stage, field research started. It was not necessary to make adjustments to the data collection instrument. Subsequently, the women were invited to participate in the research on a previously established date. Data collection was performed at the Family Health Strategy units. The final sample that composed our study, considering the missing data and without interfering with the required minimum sample size, contained 805 climacteric women. All the participants signed a consent document. They underwent anthropometric measurements and laboratory tests (after a 12-hour fast).

Abdominal obesity, assessed by the measurement of abdominal circumference, was considered the dependent variable and the cut-off point ≥ 88 cm was used, in accordance with the National Cholesterol Education Program\'s Adult Treatment Panel III (NCEP/ATP-III) \[[@pone.0237336.ref018]\], which has been employed by other studies \[[@pone.0237336.ref011], [@pone.0237336.ref019], [@pone.0237336.ref020]\] with similar population groups. Abdominal circumference was measured with a flexible, inelastic tape of the TBW^®^ brand that has a graduation interval of 0.1 cm. Abdominal circumference was measured directly on the skin, at the midpoint between the last rib and the iliac crest \[[@pone.0237336.ref021]\]. During the measurement, the woman remained in orthostatic position, with arms along the body, abdomen relaxed, looking at a fixed point in front of her \[[@pone.0237336.ref018]\]. This variable was dichotomized (obese and not obese) and the measure ≥ 88 cm was considered abdominal obesity.

The independent variables were the sociodemographic and economic data (age group, marital status, level of schooling, number of pregnancies, family income), behavioral data (intake of meat with fat, intake of chicken skin, salt in the food, fruit consumption, soft drink consumption, smoking, alcohol consumption, and physical activity level), and clinical data (climacteric stages, climacteric symptoms, depressive symptoms, anxiety symptoms, sleep quality, hormone therapy, glucose, triglycerides, total cholesterol, High Density Lipoproteins (HDL), and blood pressure).

Age group (40 to 45; 46 to 51; 52 to 65) was measured by the investigation of the woman's age: her birth month and year were asked and confirmed in an identity document. Marital status was dichotomized as with or without partner \[[@pone.0237336.ref022]\]. Level of schooling was investigated by asking the woman about the highest education level she achieved. The correspondence was performed in such a way that each grade corresponded to one year of study \[[@pone.0237336.ref022]\], categorized into three classes: primary education, secondary education and higher education. The reproductive variable was investigated by number of pregnancies and was categorized as ≤ 1; 2; and ≥ 3 \[[@pone.0237336.ref018]\].

Gross monthly family income was classified according to the amount of minimum salaries the family earned per month (when the research was carried out, one minimum salary equaled R\$ 724.00---seven hundred and twenty-four reais), and the answers were grouped into two categories: \> 1 minimum salary and ≤ 1 minimum salary.

The questions about eating habits (intake of meat with fat, of chicken skin, salt in the food, fruit consumption, soft drinks) were based on the VIGITEL questionnaire \[[@pone.0237336.ref006]\].

Intake of meat with fat and chicken with skin had five possibilities of answers and were dichotomized as no and yes. The women who answered "Always removes the visible excess"; "Does not eat red meat with too much fat nor chicken with skin"; "Does not eat red meat nor chicken skin" were considered non-consumers.

About consumption of salt in the food, there were three possible answers that were dichotomized as no and yes. The affirmative was considered "I put salt almost always, even without tasting the food". As for fruit consumption, the question referred to daily consumption and was dichotomized as: ≥ 3 fruit servings a day and ≤ 2 fruit servings a day. Concerning consumption of soft drinks, it was classified into: \< 3 times a week and ≥ 3 times a week.

Smoking and alcohol consumption were also based on VIGITEL \[[@pone.0237336.ref006]\], and the women who answered they smoke cigars or similar products were considered smokers. Alcohol consumption was considered the intake of four or more doses in one single occasion, in the 30 previous days. One dose is equivalent to one can of beer, one glass of wine or one shot of distilled spirits. Both variables were dichotomized as no and yes.

Physical activity level was measured by means of the instrument International Physical Activity Questionnaire (IPAQ), short version validated in Brazil \[[@pone.0237336.ref023]\], which classifies the person as very active, active, irregularly active and sedentary. Very active is the person who practices vigorous physical activity more than five days a week, 30 minutes per session. Active is the one who complies with the recommendation of practicing vigorous physical activity more than three days a week, in sessions that last more than 20 minutes. Irregularly active refers to the person who practices physical activity during at least ten minutes per week, which is insufficient to categorize them as active. Sedentary is the person who does not practice physical activities during at least ten continuous minutes during the week. The variable physical activity was categorized as active, irregularly active and sedentary women.

The climacteric stages were classified in the following way: premenopausal women, when their menstrual cycle was regular (28 to 28 days, 29 to 29 days), perimenopausal women, when their menstrual cycle was irregular, varying from 2 to 11 months, and postmenopausal women, when their menstrual cycle had been interrupted for more than 12 months \[[@pone.0237336.ref024]\].

The climacteric symptoms were described based on the Kupperman Index \[[@pone.0237336.ref025]\], in which the following symptoms are graduated as mild, moderate and intense: vasomotor, paresthesia, insomnia, nervousness, sadness, weakness, arthralgia/myalgia, headache, palpitations, tingling. Subsequently, this variable was dichotomized as mild and moderate/intense. Regarding hormone therapy, it was investigated whether the women were undergoing it or not.

Anxiety and depression symptoms were assessed by the Beck Anxiety Inventory (BAI) \[[@pone.0237336.ref026]\] and by the Beck Depression Inventory (BDI) \[[@pone.0237336.ref027]\], translated and validated for Brazil \[[@pone.0237336.ref028], [@pone.0237336.ref029]\]. The BAI is composed of 21 questions, each with four possibilities of answers, about how the individual felt in the previous week, expressed in common anxiety symptoms. The maximum score is 63 points and the categories are: score 0--10, minimal anxiety; 11--15, mild anxiety; 20--30, moderate anxiety; 31--63, severe anxiety \[[@pone.0237336.ref028]\]. The symptoms were dichotomized as minimal/mild and moderate/severe.

The BDI is constituted of 21 items that include symptoms and attitudes classified into four degrees of intensity. Each item presents four options and it is possible to have more than one answer in each question, but only the alternative with the highest value is considered. Total scores can vary from 0 to 63, suggesting the following degree of severity: 0--9, normal; 10--15, mild depression; 16--23, moderate depression; and 24 or more, severe depression \[[@pone.0237336.ref029]\]. The variable was categorized as normal, mild and moderate/severe.

To assess sleep quality, the Pittsburgh Sleep Quality Index, developed by Buysse *et al*. \[[@pone.0237336.ref030]\] and translated and validated for Brazilian Portuguese (PSQI-BR) \[[@pone.0237336.ref031]\], was used. The instrument assesses sleep quality in the four previous weeks and categorizes it as "well-preserved" and "impaired". It is composed of 19 questions that are analyzed by seven component scores: (1) subjective sleep quality; (2) sleep latency; (3) sleep duration; (4) habitual sleep efficiency; (5) sleep disturbances; (6) use of sleeping medication; (7) sleepiness or daytime dysfunction. The sum of these seven components yields one global score that varies from 0 to 20, where 0--4 indicate a well-preserved sleep quality and 5--20 indicate an impaired sleep quality.

Blood samples were collected for the tests of fasting blood glucose, triglycerides, total cholesterol, and HDL. Glucose results ≥100mg/dL were considered altered and \<100mg/dL, normal. Triglycerides ≥150 mg/dl was considered altered and \<150 mg/dl, normal. As for total cholesterol levels, results ≤ 190 mg/dL were considered desirable and \> 190 mg/dL were considered altered. For HDL cholesterol, results \> 40 mg/dL were considered normal and ≤ 40 mg/dL were considered low \[[@pone.0237336.ref032]\].

Blood pressure was measured using a calibrated aneroid sphygmomanometer of the OMRON^®^ brand placed on the proximal region of the left upper limb above the cubital fossa, with the patient seated, after a five-minute rest. Blood pressure was measured twice, with a one-minute interval between measures, and the mean of the results was calculated. Hypertensive women were considered those with Systolic Blood Pressure (SBP) ≥ 140 mmHg and/or Diastolic Blood Pressure (DBP) ≥ 90 mmHg \[[@pone.0237336.ref033]\].

Data were tabulated with the use of the Predictive Analytics Software (PASW) 20.0. Initially, descriptive analyses of all the variables were performed to determine their distribution and frequencies. To analyze the association between abdominal obesity (dependent variable) and the independent variables, a bivariate analysis was performed by means of Pearson's chi-square test. Considering that Poisson regression with robust variance provides correct estimates and is a better alternative for the analysis of cross-sectional studies with binary outcomes \[[@pone.0237336.ref034]\], crude prevalence ratios (PR) were calculated, with their respective confidence intervals of 95%. The variables that proved to be associated up to the level of 25% (p≤0.25) were selected for multiple Poisson regression analysis with robust variance, and adjusted prevalence ratios and their respective 95% confidence intervals (95% CI) were obtained. For the final model, the 5% level of significance (p\<0.05) was adopted.

As this study involved human beings, it was submitted to, appraised and approved by the Research Ethics Committee of the higher education institution *Faculdades Integradas Pitágoras de Montes Claros*, under opinion no. 817.666 (CAAE 36495714.0.0000.51).

Results {#sec003}
=======

Overall, 805 women participated in the study, aged 40 to 65 years---mean: 50.8 years (SD±6.98); median: 50 years. The prevalence of women with abdominal obesity was 62.4%. The mean and median of abdominal circumference were 93.0 cm.

Tables [1](#pone.0237336.t001){ref-type="table"}, [2](#pone.0237336.t002){ref-type="table"} and [3](#pone.0237336.t003){ref-type="table"} present the absolute and relative frequencies, as well as the bivariate analyses between abdominal obesity and the investigated independent variables. The independent variables selected for the multiple model were: age group (p = 0.001), level of schooling (p = 0.010), family income (p = 0.241), intake of meat with fat (p = 0.192), fruit consumption (p = 0.217), physical activity level (p˂0.001), climacteric stage (p˂0.001), climacteric symptoms (p = 0.253), hormone therapy (p = 0.166), glucose (p = 0.121), triglycerides (p = 0.055), total cholesterol (0.001), and arterial hypertension (p\<0.001).

10.1371/journal.pone.0237336.t001

###### Distribution of absolute and relative frequencies and bivariate analysis between abdominal obesity and socio-demographic and economic variables in climacteric women.

![](pone.0237336.t001){#pone.0237336.t001g}

  SOCIODEMOGRAPHIC AND ECONOMIC DATA                 Abdominal obesity          
  ------------------------------------ ------ ------ ------------------- ------ -------
  Age Group                                                                     
   40 to 45 years                      221    27.5   46.2                53.8   0.001
   46 to 51 years                      220    27.3   40.5                59.5   
   52 to 65 years                      364    45.2   30.8                69.2   
  Marital Status                                                                
    With partner                       518    64.5   39.2                60.8   0.251
    Without partner                    285    35.5   35.1                64.9   
  Level of Schooling                                                            
    Higher education                   42,2   5.3    50.0                50.0   0.011
    Secondary education                227    28.2   42.7                57.3   
    Primary education                  452    56.1   33.2                66.8   
  Number of pregnancies                                                         
   ≤ 1                                 99     12.3   42.4                57.6   0.462
   2                                   164    20.4   34.8                65.2   
   ≥ 3                                 542    67.3   37.6                62.4   
  Family income                                                                 
    \> 1 minimum salary                457    56.8   39.4                60.6   0.241
    ≤ 1 minimum salary                 348    43.2   35.3                64.7   

\* Minimum salary at the time, R\$ 724.00 (seven hundred and twenty-four reais)

10.1371/journal.pone.0237336.t002

###### Distribution of absolute and relative frequencies and bivariate analysis between abdominal obesity and behavioral variables in climacteric women.

![](pone.0237336.t002){#pone.0237336.t002g}

  BEHAVIORAL DATA                 Abdominal obesity                 
  ------------------------- ----- ------------------- ------ ------ ----------
  Intake of meat with fat                                           
    No                      665   83.3                36.8   63.2   0.192
    Yes                     133   16.7                42.9   57.1   
  Intake of chicken skin                                            
    No                      727   91.1                38.2   61.8   0.616
    Yes                     71    8.9                 35.2   64.8   
  Salt in food                                                      
    No                      789   98.1                37.6   62.4   0.852
    Yes                     15    1.9                 40.0   60.0   
  Fruit consumption                                                 
    ≥ 3 servings per day    284   35.3                40.5   59.5   0.217
    ≤ 2 servings per day    521   64.7                36.1   63.9   
  Soft drink consumption                                            
    \< 3 times a week       714   88.9                38.0   62.0   0.714
    ≥ 3 times a week        89    11.1                36.0   64.0   
  Smoking                                                           
    No                      694   86.9                38.2   61.8   0.442
    Yes                     105   13.1                34.3   65.7   
  Alcohol consumption                                               
    No                      747   92.8                38.2   61.8   0.281
    Yes                     58    7.2                 31.0   69.0   
  Physical activity level                                           
    Very active             \-    \-                  \-     \-     
    Active                  104   12.9                55.8   44.2   \< 0.001
    Irregularly active      449   55.8                34.3   65.7   
    Sedentary               252   31.3                36.1   63.9   

10.1371/journal.pone.0237336.t003

###### Distribution of absolute and relative frequencies and bivariate analysis between abdominal obesity and clinical variables in climacteric women.

![](pone.0237336.t003){#pone.0237336.t003g}

  CLINICAL DATA                Abdominal obesity                 
  ---------------------- ----- ------------------- ------ ------ ----------
  Climacteric Stages                                             
    Premenopause         219   27.3                46.1   53.9   0.001
    Perimenopause        220   27.4                40.5   59.5   
    Postmenopause        364   45.3                30.8   69.2   
  Climacteric Symptoms                                           
    Mild                 491   61.1                39.3   60.7   0.235
    Moderate/Intense     313   38.9                35.1   64.9   
  Hormone therapy                                                
    No                   746   93.9                37.0   63.0   0.166
    Yes                  49    6.1                 46.9   53.1   
  Depressive Symptoms                                            
   Normal                485   60.2                39.0   61.0   0.571
   Mild                  205   25.5                36.6   63.4   
   Moderate / Severe     112   13.9                33.9   66.1   
  Anxiety Symptoms                                               
    Minimal / Mild       552   68.7                37.1   62.9   0.683
    Moderate / Severe    251   31.3                38.6   61.4   
  Sleep Quality                                                  
    Well-preserved       617   77                  38.7   61.3   0.269
    Impaired             184   23                  34.2   65.8   
  Glucose                                                        
    Normal               633   78.6                39.0   61.0   0.121
    Altered              172   21.4                32.6   67.4   
  Triglycerides                                                  
    Normal               356   53                  41.0   59.0   0.055
    Altered              402   47                  34.3   65.7   
  Total cholesterol                                              
    Desirable            302   39.5                42.7   57.3   0.001
    Altered              461   60.5                29.5   70.5   
  HDL cholesterol                                                
    Normal               302   39.6                40.1   59.9   0.313
    Low                  461   60.4                36.4   63.6   
  Blood pressure                                                 
    Not hypertensive     511   63.9                45.6   54.4   \< 0.001
    Hypertensive         289   36.1                23.2   76.8   

When we performed the adjusted multiple model, we found that the women who were irregularly active and sedentary, those with altered cholesterol levels, and the hypertensive women remained associated with abdominal obesity. The prevalence ratios with their respective confidence intervals are presented in [Table 4](#pone.0237336.t004){ref-type="table"}.

10.1371/journal.pone.0237336.t004

###### Factors associated with abdominal obesity in climacteric women.

![](pone.0237336.t004){#pone.0237336.t004g}

  Variables                 PR (95%CI)[\*](#t004fn001){ref-type="table-fn"} adjusted
  ------------------------- ----------------------------------------------------------
  Physical activity level   
    Active                  1
    Irregularly active      1.39 (1.09--1.78)
    Sedentary               1.44 (1.13--1.82)
  Cholesterol               
    Normal                  1
   Altered                  1.21 (1.07--1.37)
  Blood pressure            
    Not hypertensive        1
    Hypertensive            1.31 (1.18--1.47)

(\*) PR: Prevalence ratio; 95%CI: Confidence Interval of 95%

Discussion {#sec004}
==========

This study revealed a high prevalence of abdominal obesity among climacteric women, as approximately two thirds of the participants presented this health problem. Such high occurrence was associated with irregularly active and sedentary women, women with altered cholesterol levels, and hypertensive women.

Prevalence of abdominal obesity was similar to the values found in other studies carried out in Brazil \[[@pone.0237336.ref011], [@pone.0237336.ref019], [@pone.0237336.ref020]\] that used the same cut-off point of 88 cm. One of the studies was conducted with 456 postmenopausal women aged 45--69 years \[[@pone.0237336.ref019]\], another study involved climacteric women aged 40--65 years assisted at private gynecology offices in the State of Minas Gerais \[[@pone.0237336.ref011]\], and the third study was carried out with 201 women aged 44--65 years assisted at the Central Outpatient Clinic of the University of Caxias do Sul \[[@pone.0237336.ref020]\].

In articles in which the cut-off point for waist circumference was 80 cm, a similar prevalence was found among pre- and postmenopausal women \[[@pone.0237336.ref035]\], and the prevalence found in studies conducted in Maringá (State of Paraná) \[[@pone.0237336.ref036]\] and Rio de Janeiro \[[@pone.0237336.ref037]\] was lower.

In the Brazilian literature, in addition to different cut-off points for the assessment of abdominal adiposity, abdominal circumference and waist circumference are measured in distinct ways, which can generate incoherence in the interpretation of results \[[@pone.0237336.ref038]\]. The most used definition, which was employed in the present study, determines that abdominal circumference is located between the last ribs and the iliac crest, in its largest perimeter, and can coincide with the umbilical scar or not. Waist circumference, in turn, is measured at the point that has the smallest perimeter of the region \[[@pone.0237336.ref021]\]. This information is relevant because different cut-off points and measurement locations generate equivocal prevalence values, hindering the design of strategies for improved prevention. It is important to standardize the cut-off point and its measurement for the investigated population.

In relation to the mean of the abdominal circumference, a study \[[@pone.0237336.ref039]\] carried out with postmenopausal women found a mean of 94.8 cm. In another study \[[@pone.0237336.ref040]\] involving women aged between 40 and 65 years, the mean was 95.7 cm. These results are similar to the ones found in our study and show that the climacteric brings changes in body composition. Abdominal obesity is an independent parameter even among people with normal BMI \[[@pone.0237336.ref041]\]; therefore, the measurement of abdominal circumference should be routinely performed by Primary Care professionals in climacteric women. When this measure increases, it becomes an indicator for the development of metabolic changes which, associated, can increase the risk of cardiovascular problems.

In our study, abdominal obesity was associated with irregularly active and sedentary women. A research carried out in the United States from 1988 to 2010 found that the association between abdominal obesity and level of physical activity is significant \[[@pone.0237336.ref041]\]. Physical activity protects against cardiovascular problems and is a preventive, non-pharmacological method; therefore, it must be a routine practice \[[@pone.0237336.ref037], [@pone.0237336.ref041]\].

A study that compared results before and after a standard twelve-week exercise program revealed a significant reduction in abdominal circumference \[[@pone.0237336.ref039]\]. Another study was carried out with postmenopausal women in the threshold for overweight. One group was submitted to a physical training program and the control group was authorized to continue with its normal level of physical activity. After one year, a reduction in waist circumference was found in both groups, and it was significant in the group that underwent the training program \[[@pone.0237336.ref041]\].

A divergent result was found in a study with postmenopausal Nigerian women, whose objective was to investigate the association between level of physical activity, general obesity and abdominal obesity. The researchers did not find a significant association of these variables after a logistic regression analysis \[[@pone.0237336.ref042]\].

A prospective Danish research with 26,625 middle-aged healthy individuals aimed to investigate the association between waist circumference alterations and mortality. It concluded that this association was positive, as individuals can benefit from a weight loss that selectively reduces abdominal fat, but if the weight loss reduces the lean body mass, this can cause harmful effects on health \[[@pone.0237336.ref043]\]. This result shows the importance of physical activity so that the individual does not lose lean body mass when he/she loses weight.

Total cholesterol was another variable associated with abdominal obesity. A similar result was found in a study conducted with obese climacteric women assisted at Family Health Strategy units, which identified high total cholesterol levels \[[@pone.0237336.ref044]\]. In a study conducted in the State of Minas Gerais with postmenopausal women, it was possible to see that the majority presented high levels of total cholesterol \[[@pone.0237336.ref045]\]. A research carried out in the State of Rio Grande do Sul found that postmenopausal women, in addition to presenting higher values of abdominal circumference, also presented higher values of total cholesterol when compared to premenopausal women \[[@pone.0237336.ref046]\].

The association between dyslipidemia and obesity is frequent, mainly in older individuals. The increase in cholesterol levels is explained by metabolic complications, as there is a deregulation of the lipolysis process that results in a greater release of fatty acids and glycerol. Adipose tissue is the body\'s largest cholesterol reservoir \[[@pone.0237336.ref047]\].

Hypertension was associated with abdominal obesity and this result was also found in a cross-sectional study with rural Chinese women aged 35 to 65 years and older \[[@pone.0237336.ref048]\]. A cohort study \[[@pone.0237336.ref049]\] carried out in China for 22 years with 12,907 participants showed that abdominal circumference and body mass index predicted the development of hypertension. As these measures are simple, effective and widely applicable, the authors recommend that they should be used as predictors of hypertension in public health strategies \[[@pone.0237336.ref049]\]. According to them, measuring abdominal circumference is necessary because not only the amount of fat, but also the location of specific fat deposits is important for the development of hypertension \[[@pone.0237336.ref049], [@pone.0237336.ref050]\].

In Brazilian studies \[[@pone.0237336.ref037], [@pone.0237336.ref051]\], hypertension has also been associated with abdominal obesity. The study conducted in Rio de Janeiro \[[@pone.0237336.ref037]\] that found a high prevalence of abdominal obesity also showed a higher chance of having arterial hypertension. A study carried out with women assisted at a Family Health Strategy unit located in the State of São Paulo, in which the cut-off point was 88 cm, showed that a large abdominal circumference increased the prevalence of hypertension \[[@pone.0237336.ref051]\]. A study with hypertensive individuals showed that they presented higher values of anthropometric measures and that abdominal circumference can predict hypertension and be a useful screening tool \[[@pone.0237336.ref052]\].

The mechanisms of hypertension in obesity are various, but this association has not been totally explained yet. It is known that blood pressure increases with weight gain and with visceral deposition \[[@pone.0237336.ref049], [@pone.0237336.ref053]\].

The present study has a cross-sectional design that does not allow to establish cause-and-effect relationships. Another limitation is that it is based on self-reports to assess behavioral aspects and some issues of clinical aspects, like climacteric stages and symptoms, depressive and anxiety symptoms, and sleep quality. However, the relevance of the results must be highlighted. In addition to having a large selected sample, representative of the population, it was possible to see that the associated variables suggest that the measurement of abdominal circumference must be considered important and incorporated by Primary Care professionals. After all, it is easy, fast and has no cost. In addition, it is important to emphasize that physical activity, the monitoring of blood pressure levels and of cholesterol levels must be encouraged during clinical practice.

Conclusion {#sec005}
==========

In the present study with climacteric women, the prevalence of abdominal obesity was high and was associated with physical inactivity, total cholesterol levels and hypertension. In light of these results, we believe that the measurement of abdominal circumference must be valued and adopted as a routine procedure by Primary Care professionals.

Further research, mainly longitudinal studies, can contribute to clarify this marker for climacteric women's health.
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PLOS ONE

Dear Dr. Piana Santos Lima de Oliveira,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

SPECIFIC ACADEMIC EDITOR COMMENTS: Your manuscript was handled by an expert reviewer in the field. Although interest was found in your study, there were several major comments that arose during the review. For instance, it does not seem as if a thorough review of the literature was included to rationalize the experimental design; several vague comments require clarification; and there are suggestions to strengthen the data presentation.

We would appreciate receiving your revised manuscript by May 01 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Frank T. Spradley

Academic Editor

PLOS ONE

Journal requirements:

1\. When submitting your revision, we need you to address these additional requirements.

 

Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. 

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (<http://learn.aje.com/plos/>) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website ([www.editage.com](http://www.editage.com)) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

The name of the colleague or the details of the professional service that edited your manuscriptA copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a \*supporting information\* file)A clean copy of the edited manuscript (uploaded as the new \*manuscript\* file)

3\. Thank you for including your ethics statement:

\"The participants agreed to respond to this research voluntarily by signing the Free and Informed Consent Form. The project was submitted, analyzed and approved for execution by the Ethics and Research Committee, nº 817.666 (CAAE 36495714.0.0000.51).\"

i\) Please amend your current ethics statement to include the full name of the ethics committee/institutional review board(s) that approved your specific study.

ii\) Once you have amended this statement in the Methods section of the manuscript, please add the same text to the "Ethics Statement" field of the submission form (via "Edit Submission").

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to <http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research>.

4\. We note that your recently published article (Marques, Maria Suzana, et al. \"Health conditions associated with overweight in climacteric women.\" PloS one 14.12 (2019).), is related to the present study, as the same sample population was considered, and the same scale adopted. To meet PLOS ONE criteria on related manuscripts (<http://journals.plos.org/plosone/s/submission-guidelines#loc-related-manuscripts>), we would ask that the previous analysis is adequately mentioned and cited (not only in the Abstract) in the present submission, and the rationale of these separate analyses is clearly discussed; moreover, please discuss why the number of participants included in the two studies is slightly different.

5\. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. Moreover, please include more details on how the questionnaire was pre-tested, and whether it was validated.

6\. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: <http://journals.plos.org/plosone/s/supporting-information>.

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: No

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: No

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: No

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The literature review seems not have been fully explored in order to support the choice of variables included in study.

It is not clear if this study is part of a bigger research project. If yes, it should be mentioned and explained, specially about the strategies of recruitment and selection of participants, quality control protocols for anthopometric mesures and choice of the questionaires.

It should be explained that Family Health Strategy is a Brazilian government strategy for organizing the primary health care, and the Family Health Care Units where people receive health care. It should be informed the referent cathegory for each variable, it is not clear. The translation and validation of the Pittsburgh Sleep Quality Index was not mentioned. There are some part of text in portugues, please see lines 191-192, 296-297.

The tables should be revised. Please, see the absolute numbers and percentages of variables \"tryglicedies\" and \"total cholesterol\". The absolute numbers of cathegories \"not obese\" and \"obese\" could be excluded, lefting just the percentages. On the table 4 should be excluded p value since it already show confidence intervals.

Please, do not present percentages on the discussion section. Data discussion seems not to be deeply explored by authors, specially not regarding gender aspects. The transversal framework of study is a limitation that was not mentioned. Conclusion are not properly presented, this manuscript section should not show percentagem.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Author response to Decision Letter 0

7 Jun 2020

Dear Editor and Reviewers.

Attending the reviewers' recommendations, we described below the modifications made in the manuscript.

1\) Please amend your current ethics statement to include the full name of the ethics committee/institutional review board(s) that approved your specific study.

RESPONSE: It was included

2\) We note that your recently published article (Marques, Maria Suzana, et al. \"Health conditions associated with overweight in climacteric women.\" PloS one 14.12 (2019).), is related to the present study, as the same sample population was considered, and the same scale adopted. To meet PLOS ONE criteria on related manuscripts (<http://journals.plos.org/plosone/s/submission-guidelines#loc-related-manuscripts>), we would ask that the previous analysis is adequately mentioned and cited (not only in the Abstract) in the present submission, and the rationale of these separate analyses is clearly discussed; moreover, please discuss why the number of participants included in the two studies is slightly different.

RESPONSE: This part of the methods section has been included for better understanding.

Regarding the different number in the final sample, the first reason was due to the classification of menopause, we used the one performed by the sample and not by age, therefore having seven people missing. The second reason referred to those women who did not answer the questionnaire about food and we believe it is essential for the dependent variable. But we think it is unnecessary to include this justification in the article once it has met the necessary number of participants according to the sample calculation.

3\) Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. Moreover, please include more details on how the questionnaire was pre-tested, and whether it was validated.

RESPONSE: Additional information was included.

4\) Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: <http://journals.plos.org/plosone/s/supporting-information>.

RESPONSE: It was included.

5\) The literature review seems not have been fully explored in order to support the choice of variables included in study.

RESPONSE: The literature review was revised and supports the choice of variables included in the study. We would like to point out that the manuscript is part of a master\'s dissertation, where the literature review was evaluated by qualification and defense boards.

6\) It is not clear if this study is part of a bigger research project. If yes, it should be mentioned and explained, specially about the strategies of recruitment and selection of participants, quality control protocols for anthopometric mesures and choice of the questionaires.

RESPONSE: We have added this information in the text.

7\) It should be explained that Family Health Strategy is a Brazilian government strategy for organizing the primary health care, and the Family Health Care Units where people receive health care.

RESPONSE: It was explained.

8\) It should be informed the referent cathegory for each variable, it is not clear.

RESPONSE: The categories of the variables were better informed.

9\) The translation and validation of the Pittsburgh Sleep Quality Index was not mentioned. There are some part of text in Portuguese, please see lines 191-192, 296-297.

RESPONSE: We included this information. We corrected the parts that were written in Portuguese". All text has been revised to English.

10\) The tables should be revised. Please, see the absolute numbers and percentages of variables \"tryglicedies\" and \"total cholesterol\". The absolute numbers of cathegories \"not obese\" and \"obese\" could be excluded, lefting just the percentages.

RESPONSE: The tables have been revised. We excluded the absolute numbers.

11\) On the table 4 should be excluded p value since it already show confidence intervals.

RESPONSE: P value was excluded.

12\) Please, do not present percentages on the discussion section.

RESPONSE: We removed the percentages from the discussion section.

13\) Data discussion seems not to be deeply explored by authors, specially not regarding gender aspects.

RESPONSE: We verified that there is no way to discuss gender aspects. Male gender was not an analyzed variable.

14\) The transversal framework of study is a limitation that was not mentioned.

RESPONSE: We added this limitation.

15\) Conclusion are not properly presented, this manuscript section should not show percentage.

RESPONSE: The percentage has been removed from conclusion section.

Sincerely,

The authors

Dear Editor and Reviewers.

Attending the reviewers' recommendations, we described below the modifications made in the manuscript.

1\) 1) Thank you for your resubmission. We note that the following request has not been addressed: We note that your recently published article (Marques, Maria Suzana, et al. \"Health conditions associated with overweight in climacteric women.\" PloS one 14.12 (2019).), is related to the present study, as the same sample population was considered, and the same scale adopted. To meet PLOS ONE criteria on related manuscripts (<http://journals.plos.org/plosone/s/submission-guidelines#loc-related-manuscripts>), we would ask that the previous analysis is adequately mentioned and cited (not only in the Cover letter) in the present submission, and the rationale of these separate analyses is clearly discussed.

RESPONSE: We have added this information in the text. The text has been revised accordingly so that this information is described in more detail (line 88-99).

Sincerely,

The authors
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Click here for additional data file.
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Abdominal obesity and association with sociodemographic, behavioral and clinical data in climacteric women assisted in Primary Care

PLOS ONE

Dear Dr. Piana Santos Lima de Oliveira,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

SPECIFIC ACADEMIC EDITOR COMMENTS: We apologize for the delay in reviewing your revised manuscript. The previous reviewer had issues with COVID-19 and had to opt out of re-reviewing your manuscript. However, as academic editor, I have proofed the manuscript and related revisions. Although the majority of comments were addressed appropriately, I think it would be a good idea to better state somewhere within lines 88-99 what is novel about this study by including a directional hypothesis statement (to match one included in the abstract and introduction), as this seems to be a re-analysis of data collected from an already-published cohort.

Please submit your revised manuscript by Aug 16 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <plosone@plos.org>. When you\'re ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled \'Manuscript\'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

We look forward to receiving your revised manuscript.

Kind regards,

Frank T. Spradley

Academic Editor

PLOS ONE

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0237336.r004

Author response to Decision Letter 1

22 Jul 2020

Dear Editor,

Attending the specific academic editor comments, we described below the modifications made in the manuscript.

1\) Although the majority of comments were addressed appropriately, I think it would be a good idea to better state somewhere within lines 88-99 what is novel about this study by including a directional hypothesis statement (to match one included in the abstract and introduction), as this seems to be a re-analysis of data collected from an already-published cohort.

RESPONSE: We have added this information in the text. The text has been revised accordingly so that this information is described in more detail (line 94-98). When reviewing the text, some information was moved from paragraph to paragraph as noted in the lines (119-120) and (129-130). All changes are highlighted in red in the body of the text.

Sincerely,

The authors
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Submitted filename: Response to Reviewers 3.docx
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Click here for additional data file.
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PONE-D-20-04707R2

Dear Dr. Piana Santos Lima de Oliveira,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Frank T. Spradley

Academic Editor

PLOS ONE

10.1371/journal.pone.0237336.r006
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This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
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PONE-D-20-04707R2

Abdominal obesity and association with sociodemographic, behavioral and clinical data in climacteric women assisted in Primary Care

Dear Dr. Piana Santos Lima de Oliveira:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Frank T. Spradley

Academic Editor

PLOS ONE
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